IRIDEX Corporation (IRIX) DCF Valuation

IRIDEX Corporation (IRIX) DCF Valuation
  • Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • Professional Design: Trusted, Industry-Standard Templates
  • Pre-Built For Quick And Efficient Use
  • No Expertise Is Needed; Easy To Follow

IRIDEX Corporation (IRIX) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Explore the financial prospects of IRIDEX Corporation (IRIX) with our user-friendly DCF Calculator! Enter your assumptions regarding growth, margins, and expenses to calculate the intrinsic value of IRIDEX Corporation (IRIX) and enhance your investment strategy.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019
AY2
2020
AY3
2021
AY4
2022
AY5
2023
FY1
2024
FY2
2025
FY3
2026
FY4
2027
FY5
2028
Revenue 43.4 36.3 53.9 57.0 51.9 55.6 59.6 63.9 68.4 73.3
Revenue Growth, % 0 -16.34 48.3 5.69 -8.96 7.17 7.17 7.17 7.17 7.17
EBITDA -8.3 -6.1 -6.7 -6.1 -8.0 -8.3 -8.9 -9.5 -10.2 -10.9
EBITDA, % -19.07 -16.72 -12.49 -10.7 -15.38 -14.87 -14.87 -14.87 -14.87 -14.87
Depreciation .7 .5 .8 1.4 2.0 1.2 1.3 1.4 1.5 1.6
Depreciation, % 1.58 1.39 1.49 2.43 3.92 2.16 2.16 2.16 2.16 2.16
EBIT -9.0 -6.6 -7.5 -7.5 -10.0 -9.5 -10.1 -10.9 -11.7 -12.5
EBIT, % -20.66 -18.11 -13.98 -13.13 -19.29 -17.03 -17.03 -17.03 -17.03 -17.03
Total Cash 12.7 11.6 23.9 13.9 7.0 15.9 17.1 18.3 19.6 21.0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 9.3 7.3 9.7 9.8 9.7
Account Receivables, % 21.46 20.05 18.02 17.15 18.61
Inventories 8.2 5.7 7.6 10.6 9.9 9.6 10.3 11.0 11.8 12.7
Inventories, % 18.81 15.72 14.13 18.62 19.1 17.28 17.28 17.28 17.28 17.28
Accounts Payable 2.6 1.1 2.8 3.9 4.5 3.3 3.5 3.8 4.1 4.4
Accounts Payable, % 5.97 3.16 5.14 6.77 8.67 5.94 5.94 5.94 5.94 5.94
Capital Expenditure -.1 -.1 -.2 -.3 -.1 -.2 -.2 -.2 -.2 -.2
Capital Expenditure, % -0.29461 -0.26687 -0.39515 -0.502 -0.21014 -0.33376 -0.33376 -0.33376 -0.33376 -0.33376
Tax Rate, % -0.94937 -0.94937 -0.94937 -0.94937 -0.94937 -0.94937 -0.94937 -0.94937 -0.94937 -0.94937
EBITAT -9.0 -6.6 -7.6 -7.5 -10.1 -9.5 -10.1 -10.9 -11.7 -12.5
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -23.4 -3.2 -9.7 -8.4 -6.7 -10.3 -10.3 -11.0 -11.8 -12.6
WACC, % 7.92 7.92 7.92 7.92 7.92 7.92 7.92 7.92 7.92 7.92
PV UFCF
SUM PV UFCF -44.4
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -13
Terminal Value -218
Present Terminal Value -149
Enterprise Value -193
Net Debt -4
Equity Value -189
Diluted Shares Outstanding, MM 16
Equity Value Per Share -11.71

What You Will Get

  • Real IRIDEX Financial Data: Pre-filled with IRIDEX Corporation’s historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See IRIDEX's intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • Comprehensive IRIDEX Data: Pre-loaded with IRIDEX Corporation's historical performance metrics and future growth estimates.
  • Customizable Assumptions: Modify parameters such as revenue growth rates, profit margins, discount rates, tax obligations, and capital investments.
  • Interactive Valuation Framework: Real-time adjustments to Net Present Value (NPV) and intrinsic value based on user-defined inputs.
  • Multiple Scenario Analysis: Develop various forecasting scenarios to evaluate different valuation results.
  • Intuitive User Interface: Clean, organized design suitable for both seasoned professionals and newcomers.

How It Works

  • Step 1: Download the prebuilt Excel template featuring IRIDEX Corporation's (IRIX) data.
  • Step 2: Examine the pre-filled sheets to grasp the essential metrics.
  • Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly see the recalculated results, including IRIDEX Corporation's (IRIX) intrinsic value.
  • Step 5: Make well-informed investment decisions or create reports based on the outputs.

Why Choose IRIDEX Corporation (IRIX)?

  • Innovative Solutions: Cutting-edge technology designed to enhance patient care and outcomes.
  • Proven Track Record: Established history of delivering reliable and effective medical devices.
  • Commitment to Quality: Rigorous standards ensure the highest level of product performance and safety.
  • Expert Support: Dedicated customer service team ready to assist with any inquiries or challenges.
  • Industry Recognition: A trusted name among healthcare professionals and institutions worldwide.

Who Should Use This Product?

  • Professional Investors: Develop comprehensive and accurate valuation models for analyzing portfolios involving IRIDEX Corporation (IRIX).
  • Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
  • Consultants and Advisors: Deliver precise valuation insights to clients interested in investing in IRIDEX Corporation (IRIX).
  • Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling related to IRIDEX Corporation (IRIX).
  • Tech Enthusiasts: Gain insights into the market valuation of tech firms like IRIDEX Corporation (IRIX).

What the Template Contains

  • Pre-Filled Data: Includes IRIDEX Corporation's historical financials and forecasts.
  • Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
  • Key Financial Ratios: Analyze IRIDEX Corporation's profitability, efficiency, and leverage.
  • Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
  • Clear Dashboard: Charts and tables summarizing key valuation results.